Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solomon Tesfaye

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Pain|June 5, 2013
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic painSolomon Tesfaye, Stefan Wilhelm, Alberto Lledo, et al.
Pain|August 14, 2023
Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy StudyEmmanuel Bäckryd, Andreas Themistocleous, Niclas Stensson, et al.
Diabetes Care|March 25, 2014
Magnetic resonance neuroimaging study of brain structural differences in diabetic peripheral neuropathyDinesh Selvarajah, Iain D Wilkinson, Michael Maxwell, et al.
Diabetes Care|September 9, 2010
Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications StudyMorten Charles, Sabita S Soedamah-Muthu, Solomon Tesfaye, et al.
Scientific Reports|July 24, 2024
Eleven neurology-related proteins measured in serum are positively correlated to the severity of diabetic neuropathyEmmanuel Bäckryd, Andreas Themistocleous, Anders Larsson, et al.
Clinical Medicine (London, England)|December 8, 2023
Are we missing pancreatic exocrine insufficiency in 'at-risk' groups? Prospective assessment of the current practice and yield of faecal elastase testing in patients with diabetes mellitus, HIV and/or high alcohol intakeMustafa Jalal, John S Leeds, Hey-Long Ching, et al.
Current Diabetes Reports|May 9, 2019
Painful and Painless Diabetic Neuropathies: What Is the Difference?Pallai Shillo, Gordon Sloan, Marni Greig, et al.
Pain|August 26, 2021
Hepatocyte growth factor, colony-stimulating factor 1, CD40, and 11 other inflammation-related proteins are associated with pain in diabetic neuropathy: exploration and replication serum data from the Pain in Neuropathy StudyEmmanuel Bäckryd, Andreas Themistocleous, Anders Larsson, et al.
Diabetes Care|December 20, 2023
Psychosocial Care for People With Diabetic Neuropathy: Time for ActionFrans Pouwer, Kara Mizokami-Stout, Neil D Reeves, et al.
Diabetes|May 31, 2020
Determinants of Treatment Response in Painful Diabetic Peripheral Neuropathy: A Combined Deep Sensory Phenotyping and Multimodal Brain MRI StudyIain David Wilkinson, Kevin Teh, Francesa Heiberg-Gibbons, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Pain|June 5, 2013
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic painSolomon Tesfaye, Stefan Wilhelm, Alberto Lledo, et al.
Pain|August 14, 2023
Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy StudyEmmanuel Bäckryd, Andreas Themistocleous, Niclas Stensson, et al.
Diabetes Care|March 25, 2014
Magnetic resonance neuroimaging study of brain structural differences in diabetic peripheral neuropathyDinesh Selvarajah, Iain D Wilkinson, Michael Maxwell, et al.
Diabetes Care|September 9, 2010
Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications StudyMorten Charles, Sabita S Soedamah-Muthu, Solomon Tesfaye, et al.
Scientific Reports|July 24, 2024
Eleven neurology-related proteins measured in serum are positively correlated to the severity of diabetic neuropathyEmmanuel Bäckryd, Andreas Themistocleous, Anders Larsson, et al.
Clinical Medicine (London, England)|December 8, 2023
Are we missing pancreatic exocrine insufficiency in 'at-risk' groups? Prospective assessment of the current practice and yield of faecal elastase testing in patients with diabetes mellitus, HIV and/or high alcohol intakeMustafa Jalal, John S Leeds, Hey-Long Ching, et al.
Current Diabetes Reports|May 9, 2019
Painful and Painless Diabetic Neuropathies: What Is the Difference?Pallai Shillo, Gordon Sloan, Marni Greig, et al.
Pain|August 26, 2021
Hepatocyte growth factor, colony-stimulating factor 1, CD40, and 11 other inflammation-related proteins are associated with pain in diabetic neuropathy: exploration and replication serum data from the Pain in Neuropathy StudyEmmanuel Bäckryd, Andreas Themistocleous, Anders Larsson, et al.
Diabetes Care|December 20, 2023
Psychosocial Care for People With Diabetic Neuropathy: Time for ActionFrans Pouwer, Kara Mizokami-Stout, Neil D Reeves, et al.
Diabetes|May 31, 2020
Determinants of Treatment Response in Painful Diabetic Peripheral Neuropathy: A Combined Deep Sensory Phenotyping and Multimodal Brain MRI StudyIain David Wilkinson, Kevin Teh, Francesa Heiberg-Gibbons, et al.
Pageof 16